Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications; during long term stability testing.
| Brand name | LANSOPRAZOLE |
| Generic name | LANSOPRAZOLE |
| Active ingredient(s) | LANSOPRAZOLE |
| Distributed by / for | Dr. Reddy's Laboratories, Inc. |
| NDC | 55111-398-30 |
| Full product label | Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle, (55111-398-90), Rx Only, Manufactured. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India |
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
| Distribution | Nationwide in the USA |
| Quantity | 8,352 bottles (30-count), 1,368 bottles (90-count) |
| Recall initiated | 2022-03-23 |
| Report date | 2022-04-06 |
| Recall completed | 2024-02-02 |
| Recall number | D-0737-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗